posted
rumor of short position needed to cover of 25m shares after FS >>> similar situation as AWYB - PAVC
great volume and up big today - will continue tuesday
Feb 16, 2007 (*********wire via COMTEX) -- Red Reef Laboratories International, Inc. (Pink Sheets:RRLB) feels obliged to remind market makers and the investing public that the recent six for one stock split was effected in such a way as to make the original shares obsolete, unless exchanged for new shares at our transfer agent, PacWest Transfer, LLC by making physical delivery. The pre-split original shares are not "good delivery" against the new shares which have a new CUSIP number and new Trading Symbol (RRLB). We encourage our stockholders to make the transfer as soon as possible. If there are any questions about procedure, do not hesitate to call Red Reef at 954-725-9475, or PacWest Transfer, at 540-675-3129.
IP: Logged |
posted
Red Reef Laboratories International, Inc. (Other OTC:RRLB.PK - News) anticipating growth announces the formation of an Advisory Board. Red Reef Labs' plans for future development and growth will require expertise and skills that management has made available through the formation of an elite Advisory Board.
Mr. Jordan Serlin, a shareholder in Red Reef contacted management and suggested the company form an Advisory Board and offered his services. Management seized the opportunity to add Mr. Serlin's broad experience and knowledge in development stage companies to the decision making process at Red Reef.
Mr. Serlin is currently President of Cenuco, Inc., a division of Ascendia Brands (AMEX:ASB - News). Cenuco is a leading pioneer in cellular software services. Mr. Serlin has served in this post since 2003. The company moved to the American Stock exchange in 2004, under Mr. Serlin's direction, reaching nearly $100 million in market value. Named one of Silicon Alley Reporter's ``Top Internet Entrepreneurs to Watch'' in the 1990s, Mr. Serlin served as the Chief Marketing Officer for ***************, helping to guide that firm to a $90 million Initial Public Offering, and a revenue sharing engagement with Time Warner, Inc., valued in excess of $100 million. Mr. Serlin was also the founding CEO for WeMedia.com, the world's first Internet portal for people with disabilities. He sold his interest in the company in a private sale in 1999 for a non-published amount.
IP: Logged |
Red Reef Laboratories International, Inc. Requests Consistent Enforcement of SEC Rules
PrimeZone "PrimeZone "
DEERFIELD BEACH, Fla., Feb. 21, 2007 (PRIME NEWSWIRE) -- Red Reef Laboratories International, Inc.'s (Pink Sheets:RRLB) Executive Vice President Peter Versace says, "Everyone is entitled to an opinion. But enough is enough!" Following is a letter Red Reef Labs sent to the Chairman and Commissioners of The Securities and Exchange Commission today in an effort to help establish an orderly market in the shares of Red Reef Labs and all emerging growth companies.
February 21, 2007
Chairman Christopher Cox SEC Headquarters 100 F Street, NE Washington, DC 20549
Dear Chairman Cox,
Everyone, even remotely aware of equity markets and small cap trading has heard of companies that have fallen victim to illegal, aggressive short selling. Investors, who are willing to accept measured risk for the potential of greater returns, are entitled to a level playing field. Hundreds of investors and entrepreneurs are adversely affected by short-sellers whose profits depend on their efforts to destroy a company's ability to access equity capital. Constant, unrelenting pressure on publicly traded shares makes it unattractive to potential investors, seeking ground floor opportunities. This culture of greed, abetted by little or no consequences to their illegal and immoral behavior, hurts all Americans by discouraging new companies from "going public", and equity players from making capital available to start-ups and emerging growth companies. These companies are the backbone of the American economy and should succeed or fail on their own merit or of their own weight.
We strongly recommend that existing rules be enforced consistently. Consideration should be given to returning to the three day settlement procedures on all "penny stocks". Delivery versus payment would virtually eliminate short selling as a means of severely harming small companies for profit.
We urge the commission to consider our suggestions and take what ever actions at your disposal to end short selling in violation of your rules, once and for all.
Yours Truly,
/signed/ ----------------------- Dr. Claus Wagner Bartak President and Chairman
Cc: Commissioner Paul S. Atkins, Commissioner Roel C. Campos, Commissioner Annette L. Nazareth, Commissioner Kathleen L. Casey, Division of Market Regulation, Division of Enforcement
Ultimately, good investor relations and earnings combine to overcome the 'forces of evil.' Red Reef Labs, keenly aware of the dynamics in play, will endure. Our plans for growth and expansion are clear and we are more than satisfied with our progress to date. Fortunately we have found creative ways to reach our objectives and though inconvenienced by market activity, are not the least bit dissuaded. We're in for the long haul. Any and all devices or tools available to discourage short selling are being considered and implemented. More importantly, we're building and growing!
Dr. Claus Wagner-Bartak added, "We are grateful and appreciative of our loyal family of shareholders and will continue to strive for the objectives you anticipated with your investment in Red Reef Labs. Though we are not yet a 'reporting company,' we have elected to have our financials audited and available to our shareholders via e-mail, on request. We are always available and glad to hear from our shareholders and potential investors."
Forward-Looking Statements
Certain statements in this news release may contain 'forward-looking' information within the meaning of the Federal securities laws. All statements, other than statements of fact, included in this release may include forward-looking statements that may involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances or to reflect unanticipated events or developments.
CONTACT: Red Reef Laboratories International, Inc. Dr. Claus Wagner-Bartak (954) 725-9475 www.rrlabs.biz
IP: Logged |
posted
Red Reef Lab's Sale of Unneeded Assets Helps Company Reduce and Reposition Debt Feb 23, 2007 8:30:00 AM 2007 *********wire, Inc.
DEERFIELD BEACH, Fla. and NAPOLEONVILLE, La., Feb. 23, 2007 (PRIME NEWSWIRE) -- Red Reef Laboratories International, Inc. (Pink Sheets:RRLB) has successfully completed the disposition of a segment of improved property containing lots that were a part of the strategic acquisition of assets from L1011 and Altfuels of Louisiana. This is the first step in the company's ongoing strategy of extracting value from this particular acquisition by recycling the proceeds of excess property and feeding into operations, resulting in organically building shareholder value.
These lots represent a portion of property not required in Red Reef's overall plans for development of the site, and the proceeds will reduce the short term obligations of the firm and assist in the repositioning of existing debt that was included in the acquisition.
Included in the original acquisition are 4 warehouses totaling 55,000 sq. ft., slated to be the future headquarters for RR Remediation operations and approximately 80 acres of land that are in the process of being evaluated for future development as a part of our recent Joint Venture with JDM Capital Corporation. Our Joint Venture, JDM Reef Capital Management, LLC is currently evaluating that longer term plan for development and will announce the progress as it becomes formed.
Red Reef Labs acquired this property primarily as headquarters for a full service remediation and EMERGENCY RESPONSE division. This location is a strong-hold for existing hurricane damage that presents the opportunity for Red Reef products to be assistive at enhancing existing protocols and issues in this hard hit area of our country. "It is foolhardy and risky to send first responders into a zone laden with bacteria, viruses and spores without first decontaminating the area to make it less hazardous. Current protocols and methods have resulted in broad spread of Katrina Cough, as yet incurable. We may be able to curtail the risk," commented Dr. Claus Wagner-Bartak, President of Red Reef.
Forward-Looking Statements
Certain statements in this news release may contain 'forward-looking' information within the meaning of the Federal securities laws. All statements, other than statements of fact, included in this release may include forward-looking statements that may involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances or to reflect unanticipated events or developments.
To access more information, please visit our web site at www.rrlabs.biz.
CONTACT: Red Reef Laboratories International, Inc. Dr. Claus Wagner-Bartak (954) 725-9475
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
